Consortium On Risk for Early-Onset Parkinson's Disease (CORE PD) - NCT00104585-02886 (Clinical Trial 123973)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy123973.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Warwick |
|
State:
|
|
RI |
| Zip Code: |
|
02886 |
| Conditions: |
|
Parkinson's Disease |
| Purpose: |
|
The purpose of this study is to investigate genetic and environmental risk factors that
increase susceptibility to the development of early-onset Parkinson's disease (developed at
or before age 50).
|
| Study summary: |
|
Parkinson's disease (PD) is a common, neurodegenerative condition. Although mostly a
late-onset disorder, 10 percent of people with PD are reported to develop symptoms before
the age of 50. To date, six genes have been found to be associated with PD, however the
majority have been found in rare PD 'families'. Some studies have also identified a number
of environmental risk factors, such as pesticide use, that appear to increase the risk of
PD.
In a previous study, Dr. Karen Marder and her research team found that close family members
of people with both early- and late-onset PD have a three-fold increased risk of PD compared
to close family members of people without PD.
The purpose of the Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) study is
to identify the genetic factors that contribute to the development of early-onset
Parkinson's disease, and to understand how these genetic factors interact with other genes
and the environment to cause PD.
Participation in the study involves a blood draw (to look for genetic factors associated
with PD), questionnaires collecting information on family and medical history, and a
neurological examination. In addition participants may be contacted in the future and asked
to participate in a more detailed interview. At that time, study investigators will also ask
participants for permission to contact family members to invite them to participate in the
study.
This research study requires participants to sign a consent form, which states that the
research is voluntary and confidential. In addition, since this is a research study, genetic
results are not released to participants or their family members now or in the future.
Scientists hope this multi-center study will increase the current knowledge of PD and that
the identification of factors that cause PD will lead to better diagnosis and treatment. |
| Criteria: |
|
Inclusion Criteria:
- Any person with Parkinson's disease in the United States whose symptoms began at age
50 or younger and was diagnosed by a neurologist. |
|
|
|
| Study is available at: |
|
Neuro Health
Warwick, RI 02886
United States
Primary Contact:
Helen Mejia-Santana, M.A.
Email: research@corepdstudy.org
Phone: 877-305-2438 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|